The European Commission recently approved Erelzi, a biosimilar etanercept drug manufactured by the Sandoz division of Switzerland’s Novartis, for…
Alice Melao
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Alice Melao
Patients with ankylosing spondylitis (AS) who smoke are twice as likely to have cumulative spinal structural damage, according to preliminary…